REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 32 filers reported holding REPROS THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $935,000 | -27.6% | 778,800 | -20.4% | 0.18% | -44.0% |
| Q4 2016 | $1,292,000 | -28.4% | 978,800 | +13.3% | 0.33% | +11.2% |
| Q3 2016 | $1,805,000 | +81.0% | 863,807 | +763.8% | 0.29% | +72.9% |
| Q4 2014 | $997,000 | -54.6% | 100,000 | -16.7% | 0.17% | -72.2% |
| Q4 2013 | $2,196,000 | – | 120,000 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,001,000 | $970,000 | 0.21% |
| Allegis Investment Advisors, LLC | 341,669 | $331,000 | 0.19% |
| GENERAL AMERICAN INVESTORS CO INC | 396,123 | $384,000 | 0.04% |
| Alambic Investment Management, L.P. | 114,591 | $111,000 | 0.04% |
| Gruss Capital Management LP | 600,000 | $582,000 | 0.02% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 102,086 | $99,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 323,429 | $314,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 27,931 | $27,000 | 0.00% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 2,700 | $3,000 | 0.00% |
| Airain ltd | 13,690 | $13,000 | 0.00% |